Donate 0 Cart Icon
Mobile Menu Shape

The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML 14 trial

Author: Burnett AK

Other Authors: Milligan D, Goldstone A, Prentice A, McMullin MF, Dennis M, Sellwood E, Pallis M, Russell N, Hills RK, Wheatley K,

Journal: British Journal of Haematology

Date: 2009